Trials / Completed
CompletedNCT00596466
Extension Study Of Long-Term Safety And Efficacy Of Pregabalin As Monotherapy (Lyrica) In Patients With Partial Seizures
An Open-Label Multicenter Extension Study To Determine Long Term Safety And Efficacy Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the long term safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy patients for the treatment of partial seizures. This is an extension study to a previous clinical trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | pregabalin | pregabalin |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2008-01-17
- Last updated
- 2021-01-26
- Results posted
- 2012-09-11
Locations
44 sites across 4 countries: United States, Czechia, Hong Kong, Ukraine
Source: ClinicalTrials.gov record NCT00596466. Inclusion in this directory is not an endorsement.